RecruitingNCT07213466
Tailored weight-management care for people with bipolarity
About this title
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Read the official source — NCT07213466Researchers study whether patterns of appetite and metabolism can guide the choice of weight-loss medicines for adults with obesity and bipolarity. Participants receive a medicine selected for their obesity profile, while researchers assess the approach’s feasibility and effects.
Medication studyAges 18–65United States
Understand this study
What is this study about?
Researchers study whether patterns of appetite and metabolism can guide the choice of weight-loss medicines for adults with obesity and bipolarity. Participants receive a medicine selected for their obesity profile, while researchers assess the approach’s feasibility and effects.
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- RochesterSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 19, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 100
- Sponsor
- Mayo Clinic
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07213466
- Official title
Show the full official title
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Rochester
Interested in joining this study?
Questions about this study
What is this study about?
Researchers study whether patterns of appetite and metabolism can guide the choice of weight-loss medicines for adults with obesity and bipolarity. Participants receive a medicine selected for their obesity profile, while researchers assess the approach’s feasibility and effects.
Who is behind this study?
The study sponsor is Mayo Clinic, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including semaglutide, Phentermine-Topiramate and naltrexone and bupropion (combination).
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
